AVBCC 2014 4th Annual Conference

Managing Cancer at the Workplace Enhances Productivity, Has Value for Employers

Wayne Kuznar

October 2014, Vol 5 , No 8 - AVBCC 2014 4th Annual Conference

Los Angeles, CA—It is a good business decision to invest in better cancer management for employees with cancer, according to Lillie D. Shockney, RN, MAS, University Distinguished Service Associate Professor of Breast Cancer, Johns Hopkins Breast Center. This type of effort can maximize the productivity of employees with cancer or cancer survivors and reduce the work-related impact on coworkers, said Ms Shockney at the Fourth Annual Conference of the Association for Value-Based Cancer Care. [ Read More ]

Does Comparative Effectiveness Research Have Value in Oncology?

Wayne Kuznar

October 2014, Vol 5 , No 8 - AVBCC 2014 4th Annual Conference

Los Angeles, CA—Can comparative effectiveness research (CER) be used for determining value in cancer care? At the Fourth Annual Conference of the Association for Value-Based Cancer Care, C. Daniel Mullins, PhD, Chairman, Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, discussed this topic (see also article in the September issue of this journal) on the challenges of applying CER into value-based oncology therapy. [ Read More ]

Patient-Centered Oncology Medical Home Improves Health Outcomes at Lower Costs to Patients and Payers

Wayne Kuznar

October 2014, Vol 5 , No 8 - AVBCC 2014 4th Annual Conference

Los Angeles, CA—Oncology practices are evolving in an era of cost containment and a renewed focus on quality. At the Fourth Annual Conference of the Association for Value-Based Cancer Care, John D. Sprandio, MD, Chief of Medical Oncology and Hematology at Oncology Management Services, Ltd, a single-specialty practice transformation company, discussed how his Pennsylvania-based integrated care delivery model has evolved to meet the parallel needs of oncology payers and patients with cancer. [ Read More ]

Payer Challenges in Oncology: Establishing Standards and Access to Quality Care

Wayne Kuznar

September 2014, Vol 5, No 7 - AVBCC 2014 4th Annual Conference

Los Angeles, CA—Payers are scrambling to devise effective strategies to cope with rapidly changing access to quality cancer care as a result of escalating costs. At the Fourth Annual Conference of the Association for Value-Based Cancer Care, John Fox, MD, MHA, Associate Vice President of Medical Affairs at Priority Health, Grand Rapids, MI, tackled changing access and payer challenges in oncology. [ Read More ]

Predictive Testing Holds More Value to Oncology Stakeholders than Prognostic Testing

Wayne Kuznar

September 2014, Vol 5, No 7 - AVBCC 2014 4th Annual Conference

Los Angeles, CA—Predictive testing offers greater value over prognostic testing to most stakeholders in cancer care, because it has a direct impact on disease treatment rather than simply predicting the course of the disease (which is, ironically, the role of prognostic testing), said S. Macey Johnson III, MBA, Vice President, Managed Care and Reimbursement, bioTheranostics, San Diego, CA, at the Fourth Annual Conference of the Association for Value-Based Cancer Care. [ Read More ]